Medpace Holdings (MEDP) reported Q4 earnings late Monday of $3.67 per diluted share, up from $2.46 a year earlier.
Analysts polled by FactSet expected $2.94.
Revenue for the quarter ended Dec. 31 was $536.6 million, up from $498.4 million a year earlier.
Analysts surveyed by FactSet expected $534.8 million.
The company said it expects full-year 2025 diluted EPS of $11.93 to $12.69 on revenue between $2.11 billion and $2.21 billion. Analysts polled by FactSet are expecting EPS of $12.52 and revenue of $2.21 billion.
Shares of the company were down 7.2% in recent after-hours activity.
Price: 328.96, Change: -25.55, Percent Change: -7.21
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。